Company Filing History:
Years Active: 2013-2016
**Title: Innovator Thomas E. Daley: Pioneering Solutions in Ethanol Intolerance**
Introduction
Thomas E. Daley, an accomplished inventor based in San Mateo, CA, has made significant contributions to the field of medical formulations. With a total of three patents to his name, Daley's work focuses on addressing ethanol intolerance, a condition that can have serious implications for health.
Latest Patents
Among his recent innovations, Daley has developed patents centered around 4-methylpyrazole formulations. His first patent describes methods and compositions designed to prevent or ameliorate ethanol intolerance. This formulation aims to reduce or alleviate symptoms associated with acetaldehyde accumulation, which can occur following ethanol consumption. His research specifically targets individuals with reduced or absent aldehyde dehydrogenase subtype 2 (ALDH2) activity, providing a therapeutic avenue to improve their quality of life. Additionally, he has created formulations of 4-methylpyrazole that remain stable under storage conditions of up to about 55°C, ensuring the practicality of his solutions.
Career Highlights
Throughout his career, Thomas E. Daley has worked with notable companies such as Raptor Pharmaceuticals Inc. and Raptor Therapeutics Inc. These positions have allowed him to further refine his innovations and significantly impact the therapeutic landscape concerning ethanol-related health issues.
Collaborations
In his journey as an inventor, Daley has collaborated with talented professionals, including Michael S. Tempesta and Elizabeth C. Squiers. Their combined expertise has undoubtedly contributed to the success of his patents and the development of valuable medical solutions.
Conclusion
Thomas E. Daley stands as a prominent figure in the realm of medical innovation, particularly regarding treatments for ethanol intolerance. His patents demonstrate a commitment to improving health outcomes for those affected by this condition. As he continues to advance his research and develop new formulations, Daley’s contributions will likely leave a lasting impact on the medical community.